Tag: Astrazeneca
AstraZeneca: FDA extends Enhertu approval
AstraZeneca announced Friday that the US FDA had approved Enhertu, the antibody-conjugate it developed with Japanese Daiichi Sankyo, in the treatment of lung cancer. The biopharmaceutical group specifies that the…
AstraZeneca: promising results in lung cancer
(CercleFinance.com) – AstraZeneca and its Japanese partner Daiichi Sankyo reported encouraging results on Tuesday for their experimental drug Datopotamab Deruxtecan in the treatment of advanced non-small cell lung cancer. According…
AstraZeneca: Encouraging results for Tagrisso
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
AstraZeneca: Enhertu approval extended to the United States
(CercleFinance.com) – AstraZeneca announced on Monday that it had received the green light from the American Food and Drug Administration (FDA) for the marketing of its immunotherapy Enhertu in the…
AstraZeneca: FDA approves Calquence tablets
(CercleFinance.com) – AstraZeneca announced Friday the approval by the FDA of Calquence tablets for the same indications as those existing for the capsule version of the drug. The biopharmaceutical group…
AstraZeneca: 48% growth in turnover
(CercleFinance.com) – AstraZeneca reports results for the first half of 2022. Total revenue increased 48% to $22,161 million, with growth coming from all therapeutic areas and the addition of Alexion.…
Market: AstraZeneca exceeds expectations in the second quarter
(Reuters) – AstraZeneca said on Friday it expects sales growth of more than 20% for the year, driven by a rise in prescriptions for its preventive treatment Evusheld against COVID-19,…
AstraZeneca exceeds expectations in the second quarter
July 29 (Reuters) – AstraZeneca said on Friday it expects sales growth of more than 20% for the year, thanks to a rise in prescriptions for its preventive treatment Evusheld…
AstraZeneca: 48% revenue growth
(CercleFinance.com) – AstraZeneca reports results for the first half of 2022. Total revenue increased 48% to $22,161 million, with growth coming from all therapeutic areas and the addition of Alexion.…
Astrazeneca: Alexion boosts sales and squeezes profits
London (awp/afp) – The British pharmaceutical group Astrazeneca, manufacturer of one of the main vaccines against Covid-19, saw its sales jump in the first half, but its profits plunged due…
AstraZeneca: Obtained priority review in the United States
(CercleFinance.com) – AstraZeneca and Daiichi Sankyo have received notification of the acceptance of Enhertu’s (trastuzumab deruxtecan) Supplemental Biologics License Application (sBLA) for the treatment of adult female patients in the…
AstraZeneca: CHMP recommends several drugs
(CercleFinance.com) – AstraZeneca announced on Monday that the Committee for Medicinal Products for Human Use (CHMP), an offshoot of the European Medicines Agency, had recommended the marketing of several of…